{"id":"W3214576279","doi":"10.1111/bjd.20885","title":"Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting","year":2021,"lang":"en","type":"letter","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; ABB (Canada); Surrey Memorial Hospital; SKiN Health; University of British Columbia; Queen's University; Probity Medical Research","funders":"AbbVie Canada","keywords":"Adalimumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Adverse effect; Methotrexate; Dermatology Life Quality Index; Clinical endpoint; Internal medicine; Quality of life (healthcare); Patient satisfaction; Physical therapy; Clinical trial; Surgery; Dermatology; Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004561465,0.0002139137,0.001325601,0.000323996,0.0004752603,0.00108663,0.0004008762,0.001012949,0.004816445],"category_scores_gemma":[0.02217664,0.0001824204,0.0007274363,0.0005756582,0.0003549336,0.0007037329,0.0002477846,0.001750265,0.0004519687],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008041595,"about_ca_system_score_gemma":0.0005515524,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001198701,"about_ca_topic_score_gemma":0.003434578,"domain_scores_codex":[0.9982968,0.0009377664,0.0001993791,0.0001312707,0.0003562594,0.00007851638],"domain_scores_gemma":[0.9859995,0.00868309,0.002924222,0.0002152397,0.001458217,0.0007197442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0687883,0.00447542,0.2270028,0.005059142,0.002442029,0.001277897,0.0009405728,0.0006156702,0.001278291,0.0004559942,0.1599134,0.5277505],"study_design_scores_gemma":[0.03642054,0.05432389,0.7808523,0.003099319,0.005320909,0.00837645,0.002498669,0.01173479,0.001996403,0.001145217,0.09389226,0.0003391922],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.8175165,0.09244074,0.001052581,0.06890413,0.008589129,0.0004061032,0.002548102,0.00008625755,0.008456386],"genre_scores_gemma":[0.9469,0.01823445,0.0021895,0.0185875,0.01148465,0.0002250377,0.0006627903,0.00003471421,0.001681235],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.004816445,"threshold_uncertainty_score":0.02412367,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01013558651661825,"score_gpt":0.2439160990480291,"score_spread":0.2337805125314109,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}